VTCN1 anticorps
-
- Antigène Voir toutes VTCN1 Anticorps
- VTCN1 (V-Set Domain Containing T Cell Activation Inhibitor 1 (VTCN1))
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp VTCN1 est non-conjugé
-
Application
- Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Marque
- IHC-plus™
- Purification
- Affinity purified
- Immunogène
- Human VTCN1
- Clone
- H74
- Isotype
- IgG1 kappa
- Top Product
- Discover our top product VTCN1 Anticorps primaire
-
-
- Indications d'application
-
Approved: Flo, IHC, IHC-P (20 μg/mL)
Usage: This H74 antibody has been tested by flow cytometric analysis of transient hB7-H4 transfected cells. This can be used at less than or equal to 0.25 μg per test. A test is defined as the amount (ug) of antibody that will stain a cell sample in a final volume of 100 μL. Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest. - Commentaires
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- Aqueous buffer, 0.09 % sodium azide. Sourced from ascites.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C
- Stockage commentaire
- Store at 2°C to 8°C.
-
-
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma." dans: Journal of cancer research and clinical oncology, (2022) (PubMed).
: "
-
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma." dans: Journal of cancer research and clinical oncology, (2022) (PubMed).
-
- Antigène
- VTCN1 (V-Set Domain Containing T Cell Activation Inhibitor 1 (VTCN1))
- Autre désignation
- VTCN1 / B7-H4 (VTCN1 Produits)
- Synonymes
- anticorps B7h4, anticorps B7s1, anticorps B7x, anticorps BC032925, anticorps B7-H4, anticorps B7H4, anticorps B7S1, anticorps B7X, anticorps B7h.5, anticorps PRO1291, anticorps VCTN1, anticorps RGD1311204, anticorps V set domain containing T cell activation inhibitor 1 L homeolog, anticorps V-set domain containing T cell activation inhibitor 1, anticorps V-set domain containing T-cell activation inhibitor 1, anticorps V set domain containing T cell activation inhibitor 1, anticorps vtcn1.L, anticorps VTCN1, anticorps vtcn1, anticorps Vtcn1
- Sujet
-
Name/Gene ID: VTCN1
Synonyms: VTCN1, B7 superfamily member 1, B7 Superfamily, member 1, B7h.5, B7S1, B7H4, PRO1291, VCTN1, RP11-229A19.4, B7 family member, H4, B7-H4, B7X, Protein B7S1 - ID gène
- 79679
- UniProt
- Q7Z7D3
-